The analysis of metabolite pool size in cancer cells showed that LIF drove glucose metabolic reprogramming; ectopic LIF expression increased the levels of intermediates of glycolysis, including 3-phosphoglycerate (3-PG), phosphoenol pyruvate (PEP), and lactate (Fig. 2G). This evidence concerns the gene LIF and cancer.